Phosphoserine Dependant Assembly of Signaling complexes
信号复合物的磷酸丝氨酸依赖性组装
基本信息
- 批准号:7283024
- 负责人:
- 金额:$ 28.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-09-01 至 2009-08-31
- 项目状态:已结题
- 来源:
- 关键词:14-3-3 ProteinsAntineoplastic AgentsBRCT DomainBindingBiochemicalBiologicalC-terminalCell CycleCell Cycle ProgressionCell Cycle RegulationCell ProliferationCell Proliferation RegulationCellsCentrosomeComplexDNA DamageDevelopmentDisease regressionDown-RegulationDrug DesignEukaryotic CellEventF-Box ProteinsFHA DomainFundingGenotoxic StressGoalsHumanLaboratoriesLigand BindingLigandsMalignant - descriptorMalignant NeoplasmsMitosisMitoticMitotic spindleMolecularN-terminalNormal CellNumbersPharmaceutical PreparationsPhosphopeptidesPhosphorylationPhosphoserinePhosphothreoninePhosphotransferasesPhysiologicalPlayPolo-Box DomainProcessProtein KinaseProtein OverexpressionProteinsProteomicsRecruitment ActivityRegulationRoleScreening procedureSignal TransductionSignaling ProteinStagingTechniquesTertiary Protein StructureThreonineTimeWD RepeatWorkbasehuman PLK1 proteinneoplasticnovelresearch studyresponsetherapeutic targettumor
项目摘要
DESCRIPTION (provided by applicant):
Phosphoserine/threonine-binding domains play critical roles in controlling multiple aspects of cell proliferation, including cell cycle progression and the cellular response to DNA damage. The current list of pSer/pThr-binding domains includes 14-3-3 proteins, FHA domains, WW domains, WD40 repeats of F-box proteins, tandem BRCT domains and the Polo-box domains of Polo-like kinases. The long-term goal of our laboratory is to identify and characterize these domains with a focus on identifying their physiological ligands, determining the structural basis for their pSer/Thr-motif recognition, and elucidating the molecular basis for their functions in cell cycle control within complex protein kinase signaling networks. Polo-like kinases are essential during multiple stages of the eukaryotic cell cycle, including many of the events that occur during M-phase, as well as in the DNA damage response. Despite their importance, details about how Polo-like kinase activity is regulated, and the identity of their substrates are poorly understood. In this proposal we use a combination of biochemical, structural and cell biological techniques to determine the function of the invariant pSer/pThr-binding Polo-box domain in regulating the activation of, and the substrate selection and phosphorylation by Polo-like kinases. In the process, we will identify many new Polo-like kinase ligands and substrates that may be responsible for the pleiotropic role these kinases play in the cell. Since Polo-like kinases are upregulated in many types of human cancer, and since their experimental down-regulation results in decreased cell proliferation and tumor regression, the results of our experiments should determine whether the Polo-box domain is a good target for novel anti-cancer drug design.
描述(由申请人提供):
项目成果
期刊论文数量(36)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cytokine-induced signaling networks prioritize dynamic range over signal strength.
- DOI:10.1016/j.cell.2008.08.034
- 发表时间:2008-10-17
- 期刊:
- 影响因子:64.5
- 作者:Janes KA;Reinhardt HC;Yaffe MB
- 通讯作者:Yaffe MB
Linear motif atlas for phosphorylation-dependent signaling.
- DOI:10.1126/scisignal.1159433
- 发表时间:2008-09-02
- 期刊:
- 影响因子:7.3
- 作者:Miller ML;Jensen LJ;Diella F;Jørgensen C;Tinti M;Li L;Hsiung M;Parker SA;Bordeaux J;Sicheritz-Ponten T;Olhovsky M;Pasculescu A;Alexander J;Knapp S;Blom N;Bork P;Li S;Cesareni G;Pawson T;Turk BE;Yaffe MB;Brunak S;Linding R
- 通讯作者:Linding R
Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2.
- DOI:10.1016/j.ceb.2009.01.018
- 发表时间:2009-04
- 期刊:
- 影响因子:7.5
- 作者:Reinhardt HC;Yaffe MB
- 通讯作者:Yaffe MB
Peptoid-Peptide hybrid ligands targeting the polo box domain of polo-like kinase 1.
- DOI:10.1002/cbic.201200206
- 发表时间:2012-06-18
- 期刊:
- 影响因子:0
- 作者:Liu F;Park JE;Qian WJ;Lim D;Scharow A;Berg T;Yaffe MB;Lee KS;Burke TR Jr
- 通讯作者:Burke TR Jr
NetworKIN: a resource for exploring cellular phosphorylation networks.
- DOI:10.1093/nar/gkm902
- 发表时间:2008-01
- 期刊:
- 影响因子:14.9
- 作者:Linding R;Jensen LJ;Pasculescu A;Olhovsky M;Colwill K;Bork P;Yaffe MB;Pawson T
- 通讯作者:Pawson T
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL B YAFFE其他文献
PLASMINOGEN DEFICIENCY OF PLEURAL FLUID DUE TO NEUTROPHIL INFLAMMATORY PROTEASE DEGREDATION IN EMPYEMA PATIENTS: A CAUSE OF INTRAPLEURAL LYTIC FAILURE?
- DOI:
10.1016/j.chest.2023.07.4196 - 发表时间:
2023-10-01 - 期刊:
- 影响因子:
- 作者:
CHRISTOPHER D BARRETT;PETER MOORE;HUNTER B MOORE;ERNEST E MOORE;JAMES G CHANDLER;ANGELA SAUAIA;KEELY BUESING;DANIEL HERSHBERGER;IVOR S DOUGLAS;ANGEL AUGUSTO DR PEREZ-CALATAYUD;MICHAEL B YAFFE - 通讯作者:
MICHAEL B YAFFE
MICHAEL B YAFFE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL B YAFFE', 18)}}的其他基金
Protein Kinase Signaling in the Genotoxic Stress Response
基因毒性应激反应中的蛋白激酶信号转导
- 批准号:
9975171 - 财政年份:2017
- 资助金额:
$ 28.22万 - 项目类别:
Protein Kinase Signaling in the Genotoxic Stress Response
基因毒性应激反应中的蛋白激酶信号转导
- 批准号:
10219250 - 财政年份:2017
- 资助金额:
$ 28.22万 - 项目类别:
Protein Kinase Signaling in the Genotoxic Stress Response
基因毒性应激反应中的蛋白激酶信号转导
- 批准号:
10664948 - 财政年份:2017
- 资助金额:
$ 28.22万 - 项目类别:
Protein Kinase Signaling in the Genotoxic Stress Response
基因毒性应激反应中的蛋白激酶信号转导
- 批准号:
9752562 - 财政年份:2017
- 资助金额:
$ 28.22万 - 项目类别:
Protein Kinase Signaling in the Genotoxic Stress Response
基因毒性应激反应中的蛋白激酶信号转导
- 批准号:
10445249 - 财政年份:2017
- 资助金额:
$ 28.22万 - 项目类别:
Phospho-Binding Ligands and Substrates of BRCA1
BRCA1 的磷酸结合配体和底物
- 批准号:
8413981 - 财政年份:2012
- 资助金额:
$ 28.22万 - 项目类别:
Phospho-Binding Ligands and Substrates of BRCA1
BRCA1 的磷酸结合配体和底物
- 批准号:
8502497 - 财政年份:2012
- 资助金额:
$ 28.22万 - 项目类别:
相似海外基金
Delays in Acquisition of Oral Antineoplastic Agents
口服抗肿瘤药物的获取延迟
- 批准号:
9975367 - 财政年份:2020
- 资助金额:
$ 28.22万 - 项目类别:
Eliminate the difficulty of venous puncture in patients receiving antineoplastic agents - Development of a new strategy for the prevention of induration-
消除接受抗肿瘤药物的患者静脉穿刺的困难 - 制定预防硬结的新策略 -
- 批准号:
16K11932 - 财政年份:2016
- 资助金额:
$ 28.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms of the antineoplastic agents inhibiting DNA replication and their applications to cancer patient treatmen
抗肿瘤药物抑制DNA复制的分子机制及其在癌症患者治疗中的应用
- 批准号:
19591274 - 财政年份:2007
- 资助金额:
$ 28.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
PNET EXPERIMENTAL THERAPEUTICS--ANTINEOPLASTIC AGENTS AND TREATMENT DELIVERY
PNET 实验治疗——抗肿瘤药物和治疗实施
- 批准号:
6346309 - 财政年份:2000
- 资助金额:
$ 28.22万 - 项目类别:
TYROSINE KINASE INHIBITORS AS ANTINEOPLASTIC AGENTS
酪氨酸激酶抑制剂作为抗肿瘤剂
- 批准号:
2885074 - 财政年份:1999
- 资助金额:
$ 28.22万 - 项目类别:
TYROSINE KINASE INHIBITORS AS ANTINEOPLASTIC AGENTS
酪氨酸激酶抑制剂作为抗肿瘤剂
- 批准号:
6174221 - 财政年份:1999
- 资助金额:
$ 28.22万 - 项目类别:














{{item.name}}会员




